↓ Skip to main content

American Association for Cancer Research

Article Metrics

BRAFV600E: Implications for Carcinogenesis and Molecular Therapy

Overview of attention for article published in Molecular Cancer Therapeutics, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
patent
4 patents

Citations

dimensions_citation
300 Dimensions

Readers on

mendeley
379 Mendeley
Title
BRAFV600E: Implications for Carcinogenesis and Molecular Therapy
Published in
Molecular Cancer Therapeutics, March 2011
DOI 10.1158/1535-7163.mct-10-0799
Pubmed ID
Authors

Emma R. Cantwell-Dorris, John J. O'Leary, Orla M. Sheils

Mendeley readers

The data shown below were compiled from readership statistics for 379 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 3 <1%
United Kingdom 2 <1%
Germany 1 <1%
India 1 <1%
South Africa 1 <1%
Brazil 1 <1%
Denmark 1 <1%
Spain 1 <1%
United States 1 <1%
Other 1 <1%
Unknown 366 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 70 18%
Student > Ph. D. Student 66 17%
Researcher 64 17%
Student > Master 47 12%
Student > Doctoral Student 24 6%
Other 63 17%
Unknown 45 12%
Readers by discipline Count As %
Agricultural and Biological Sciences 98 26%
Biochemistry, Genetics and Molecular Biology 94 25%
Medicine and Dentistry 88 23%
Immunology and Microbiology 12 3%
Pharmacology, Toxicology and Pharmaceutical Science 11 3%
Other 28 7%
Unknown 48 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2021.
All research outputs
#1,438,602
of 19,907,236 outputs
Outputs from Molecular Cancer Therapeutics
#150
of 3,456 outputs
Outputs of similar age
#45,497
of 413,221 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#2
of 56 outputs
Altmetric has tracked 19,907,236 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,456 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 413,221 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.